Upper gastrointestinal bleeding in patients with acute coronary syndromes: Clinical predictors and prophylactic role of proton pump inhibitors

Journal of Clinical Gastroenterology

Volumn 42, Issue 4, 2008, Pages 368-372

  Barada, Kassem ^a   Karrowni, Wassef ^a   Abdallah, Mouhamad ^a   Shamseddeen, Wael ^a   Sharara, Ala I ^a   Dakik, Habib A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Acute coronary syndromes; Gastrointestinal bleeding; Proton pump inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; RABEPRAZOLE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; FEMALE; HEALTH HAZARD; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; PROPHYLAXIS; UPPER GASTROINTESTINAL BLEEDING;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ACUTE CORONARY SYNDROME; AGED; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LEBANON; MALE; MIDDLE AGED; OMEPRAZOLE; PROGNOSIS; PROTON PUMP INHIBITORS; PROTON-TRANSLOCATING ATPASES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 41349123763     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31802e63ff     Document Type: Article

References (25)

1. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-2) Investigators. Single-Sbolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet. 1999;354:716-722.
2. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001;358:605-613.
3. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet. 1986;1:397-402.
4. Rasty S, Borzak S, Tisdale JE. Bleeding associated with eptafibatide targeting higher risk patients with acute coronary syndromes: incidence and multivariate risk factors. J Clin Pharmacol. 2002;42:1366-1373.
5. Pierre T, Ouimet H, McCans J, et al. Aspirin, Heparin or both to treat unstable angina. N Engl J Med. 1988;319:1105-1111.
6. The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. New Engl J Med. 1998;338:1498-1505.
7. Rothberg MB, Celestin C, Fiore LD, et al. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med. 2005;143:241-250.
8. Atar S, Cannon CP, Murphy SA, et al. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial. Am Heart J. 2006;151:976.e1-976.e6.
9. Younossi ZM, Strum WB, Schatz RA, et al. Effect of combined anticoagulation and low-dose aspirin treatment on upper gastrointestinal bleeding. Dig Dis Sci. 1997;42:79-82.
10. Patrono C, García Rodríguez LA, Landolfi R, et al. Low-dose aspirin for the prevention of atherothrombosis. New Engl J Med. 2005;353:2373-2383.
11. Diener HC, Bogousslavsky J, Brass LM, et al. MATCH investigators aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337.
12. Rao SV, O'Grady K, Pieper KS, et al. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol. 2005;96:1200-1206. [Epub 2005 September 12].
13. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24:1815-1823.
14. Cappell MS. Gastrointestinal bleeding associated with myocardial infarction [Review]. Gastroenterol Clin North Am. 2000;29:423-444.
15. Hayden M, Pignone M, Phillips C, et al. Aspirin for the primary prevention of cardiovascular events: a summary of evidence for the US. Preventive Services Task Force. Ann Intern Med. 2002;136:161-172.
16. Slattery J, Warlow CP, Shorrock CJ, et al. Risk of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - analysis of gastrointestinal bleeding during UK-TIA trial. Gut. 1995;37:509-511.
17. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996;348:423-428.
18. Turpie AG, Gent M, Laupacis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med. 1993;329:524-529.
19. Sachs G, Shin JM, Vagin O, et al. Current trends in the treatment of upper gastrointestinal disease. Best Pract Res Clin Gastroenterol. 2002;16:835-849.
20. Rockey DC. Proton pump inhibitors in acute peptic ulcer bleeding. Gastroenterology. 2005;129:756-757.
21. Lai KC, Lam SK, Chu KM, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med. 2002;346:2033-2038.
22. Chan FK, Ching JY, Hung LC, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238-244.
23. Kantorova I, Svoboda P, Scheer P, et al. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology. 2004;51:757-761.
24. Guda NM, Noonan M, Kreiner MJ, et al. Use of intravenous proton pump inhibitors in community practice: an explanation for the shortage? Am J Gastroenterol. 2004;99:1233-1237.
25. Wells PS, Forgie MA, Simms M, et al. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism. Arch Intern Med. 2003;163:917-920.